Covered recipient · General Payments record
SHAZIA SHADANI
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$1,790.41
- Reported across 114 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $271.75 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $113.24 | 6 |
| Janssen Biotech, Inc. | $47.78 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $37.53 | 2 |
| PFIZER INC. | $31.03 | 2 |
| Amgen Inc. | $28.91 | 2 |
| ANI Pharmaceuticals, Inc. | $13.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.79 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106060880 | CMS |
| ABBVIE INC. | $16.71 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106060882 | CMS |
| ABBVIE INC. | $29.78 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106060884 | CMS |
| ABBVIE INC. | $16.50 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106060886 | CMS |
| ABBVIE INC. | $17.72 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106060888 | CMS |
| ABBVIE INC. | $14.74 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106060890 | CMS |
| Amgen Inc. | $13.09 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116105158 | CMS |
| Amgen Inc. | $15.82 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116105164 | CMS |
| ANI Pharmaceuticals, Inc. | $13.26 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091133861 | CMS |
| Janssen Biotech, Inc. | $15.94 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078326455 | CMS |
| Janssen Biotech, Inc. | $17.35 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078325786 | CMS |
| Janssen Biotech, Inc. | $14.49 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078325247 | CMS |
| Novartis Pharmaceuticals Corporation | $14.66 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087281637 | CMS |
| Novartis Pharmaceuticals Corporation | $22.87 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087281647 | CMS |
| PFIZER INC. | $14.92 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131674508 | CMS |
| PFIZER INC. | $16.11 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131987737 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.